Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about MCT8: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Name | MCT8 |
| Related Diseases | Allan-Herndon-Dudley Syndrome, Cerebral Hypothyroidism, cerebral hypothyroidism, Allan-Herndon-Dudley syndrome |
| Related Pathways | Thyroid Hormone Metabolism, X-Linked Inheritance |
Knowledge base pages for this entity
graph TD
MCT8["MCT8"]
MCT8 -->|"involved_in"| Thyroid_Hormone_Metabolism["Thyroid Hormone Metabolism"]
MCT8 -->|"transports"| Thyroid_Hormone["Thyroid Hormone"]
MCT8 -->|"causes"| Allan_Herndon_Dudley_Syndrome["Allan-Herndon-Dudley Syndrome"]
MCT8 -->|"regulates"| ASTROCYTE["ASTROCYTE"]
MCT8 -->|"target for"| Cancer["Cancer"]
MCT8 -->|"target for"| Aging["Aging"]
MCT8 -->|"causes"| Als["Als"]
SLC16A2["SLC16A2"] -->|"encodes"| MCT8
AGING["AGING"] -->|"target for"| MCT8
NEURON["NEURON"] -->|"inhibits"| MCT8
SLC16A10["SLC16A10"] -->|"transports"| MCT8
SLC16A3["SLC16A3"] -->|"target for"| MCT8| Target | Relation | Type | Str |
|---|---|---|---|
| Thyroid Hormone Metabolism | involved_in | pathway | 1.00 |
| ALLAN-HERNDON-DUDLEY SYNDROME | associated_with | entity | 0.98 |
| THYROID HORMONE | associated_with | entity | 0.95 |
| Thyroid Hormone | transports | compound | 0.95 |
| Allan-Herndon-Dudley Syndrome | causes | disease | 0.95 |
| Thyroid Hormone Transport | mediates | process | 0.95 |
| NEURODEGENERATION | associated_with | entity | 0.90 |
| Cerebral Hypothyroidism | associated_with | phenotype | 0.90 |
| cerebral hypothyroidism | causes | phenotype | 0.90 |
| Thyroid Hormones | transports | molecule | 0.90 |
| ASTROCYTE | regulates | entity | 0.85 |
| X-Linked Inheritance | associated_with | mechanism | 0.85 |
| Brain | expressed_in | brain_region | 0.85 |
| Allan-Herndon-Dudley syndrome | therapeutic_target | disease | 0.80 |
| SLC16A2 | translocates_to | gene | 0.70 |
| oxidative stress response | participates_in | pathway | 0.70 |
| neurodegeneration | causes | disease | 0.70 |
| neurons | expressed_in | cell_type | 0.70 |
| Cancer | therapeutic_target | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Als | causes | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Aging | causes | disease | 0.65 |
| Als | transports | disease | 0.65 |
| Anxiety | transports | disease | 0.65 |
| Neurodegeneration | transports | disease | 0.65 |
| thyroid hormone | binds_to | drug | 0.60 |
| T3 | binds_to | drug | 0.60 |
| T4 | binds_to | drug | 0.60 |
| T3 | interacts_with | drug | 0.60 |
| thyroid hormone resistance | contributes_to | disease | 0.60 |
| blood-brain barrier | interacts_with | cell_type | 0.60 |
| hippocampal neurogenesis | involved_in | pathway | 0.60 |
| BASIGIN | interacts_with | protein | 0.60 |
| SLC16A1 | associated_with | gene | 0.60 |
| SLC16A3 | therapeutic_target | gene | 0.60 |
| ASTROCYTES | therapeutic_target | gene | 0.60 |
| RNA | causes | gene | 0.60 |
| Astrocyte | therapeutic_target | cell_type | 0.60 |
| Blood-Brain Barrier | regulates | pathway | 0.60 |
| T Cell | therapeutic_target | cell_type | 0.60 |
| Neuron | expressed_in | cell_type | 0.60 |
| Blood-Brain Barrier | causes | pathway | 0.60 |
| T Cell | causes | cell_type | 0.60 |
| Fibroblast | regulates | cell_type | 0.60 |
| Neurogenesis | associated_with | pathway | 0.60 |
| Neuron | inhibits | cell_type | 0.60 |
| Neurogenesis | activates | pathway | 0.60 |
| Neuron | associated_with | cell_type | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Thyroid Hormone | interacts_with | compound | 0.90 |
| SLC16A2 | encodes | gene | 0.60 |
| SLC16A10 | associated_with | gene | 0.60 |
| SLC16A2 | associated_with | gene | 0.60 |
| AGING | therapeutic_target | gene | 0.60 |
| SLC16A2 | causes | gene | 0.60 |
| SLC16A2 | regulates | gene | 0.60 |
| NEURON | inhibits | gene | 0.60 |
| SLC16A10 | transports | gene | 0.60 |
| SLC16A3 | therapeutic_target | gene | 0.60 |
| SLC16A2 | transports | gene | 0.60 |
| ASTROCYTES | therapeutic_target | gene | 0.60 |
| RNA | causes | gene | 0.60 |
| SLC16A1 | transports | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||